EN
HI
Summary
As of 2 Sep, 2026, Godavari Drugs stock price is ₹96.8. During the trading session, the stock has moved between an intraday low of ₹93.00 and an intraday high of ₹99.00. Over the last 52 weeks, Godavari Drugs has traded between ₹69.70 and ₹135.25.
The stock has recorded a trading volume of 14,426 shares, with a market capitalization of ₹7530500. Its Average Traded Price (ATP) is ₹96.36, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹96.80.
Godavari Drugs has an upper circuit limit of ₹116.49 and a lower circuit limit of ₹77.67. The total value traded stands at ₹13.90 L, and the delivery percentage for the day is 80.62%.
The stock is currently traded with a market lot size of 1. Godavari Drugs also offers a dividend yield of 0%.
Godavari Drugs share price chart
Godavari Drugs Share Key Metrics
Volume
14426.00
Market Cap
72.90 CR
LTQ@LTP
25@96.80
ATP
96.36
Var Margin
25 %
Circuit Range
77.67-116.49
Delivery %
80.62 %
Value
13.90 L
ASM/GSM
No
Market Lot
1
Godavari Drugs Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
41.65
Sector P/B
3.54
Sec. Div. Yield
0.5
Godavari Drugs Resistance and Support
Pivot 98.33
Resistance
First Resistance
101.76
Second Resistance
106.43
Third Resistance
109.86
Support
First Support
93.66
Second Support
90.23
Third Support
85.56
Godavari Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 02 2026 | 99 | 96.8 | -0.29% | 99 | 93 |
| Tue Sep 01 2026 | 99.9 | 97.08 | -0.94% | 103 | 94.9 |
| Mon Aug 31 2026 | 100.5 | 98 | -2.00% | 100.94 | 97.5 |
Godavari Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2026-01-15 | Preferential issue of shares |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results & A.G.M. |
| 2025-05-29 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Godavari Drugs News
Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Godavari Drugs board approved altering its Memorandum of Association to include the business of nutraceuticals, dietary supplements, natural extracts, and related products. This expansion is subject to shareholder approval at the upcoming 38th Annual General Meeting.
Sep 01 2026 11:01:32
Godavari Drugs Ltd - 530317 - Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026
Godavari Drugs confirmed no deviation in the utilization of funds from its Rs.44.11 crore preferential issue for Q1 FY27. These funds are being used for capital expenditure, working capital, and repayment of unsecured promoter loans as originally planned.
Aug 17 2026 11:40:48
Read More
Godavari Drugs Management
| Name | Position |
|---|---|
| Venkatesh Achanta | Company Secretary & Compliance Officer |
| Ghanshyam Jaju | Chairman |
Godavari Drugs Similar Stocks
Bharat Immunologicals & Biologicals Corporation Ltd.
15.55
-0.04 (0.26%)
Concord Drugs Ltd.
78.67
-3.25 (3.97%)
Everest Organics Ltd.
267.00
-10.00 (3.61%)
Aspira Pathlab & Diagnostics Ltd.
94.00
-1.39 (1.46%)
Kretto Syscon Ltd.
0.46
0.01 (2.22%)
Vasundhara Rasayans Ltd.
156.50
-2.35 (1.48%)
Fortis Malar Hospitals Ltd.
46.00
-0.65 (1.39%)
Godavari Drugs FAQs
The Buying Price of Godavari Drugs share is 96.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Godavari Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Godavari Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Godavari Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Godavari Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Godavari Drugs’s valuation compare Sector P/E, P/B which are 41.65 & 3.54 with sector averages, along with growth rates and financial metrics.
The Market Cap of Godavari Drugs is 72.90 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Godavari Drugs share price is 135.25 & 69.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Godavari Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
